Synairgen (SNG): Corp SNG001 shown to be safe in COPD patients
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Morning Note
Synairgen plc (SNG:LON) | 6.6 0 2.3% | Mkt Cap: 13.3m
- Published:
22 Jun 2018 -
Author:
Mark Brewer -
Pages:
3
Synairgen (SNG): Corp SNG001 shown to be safe in COPD patients